Litster J David

Avg. Two Year Performance

No purchase track record

11% Avg. Sale Return

5% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	3%	6%	10%	19%	11%
Sale Success Rate	4 of 9	5 of 9	5 of 9	4 of 9	3 of 9

Novellus Systems Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--